Loading clinical trials...
Loading clinical trials...
The study hypothesis is that the test and treat model utilizing video-based patient education will have higher rates of hepatitis C virus (HCV) treatment initiation and treatment completion.
Viral hepatitis C (HCV) represents a major public health concern and is associated with significant morbidity and mortality. HCV screening and treatment among people who use drugs is challenging due to barriers leading to loss within HCV care cascades at most centers providing addiction care. One critical element that would improve access to HCV therapy would be a test, educate and treat system, where people obtain drug on the same day as they are confirmed as Hepatitis C viremic.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
Phoenix House
Long Island City, New York, United States
ColumbiaDoctors Midtown
New York, New York, United States
Weill Cornell Medicine Midtown Center for Treatment and Research
New York, New York, United States
Start Date
November 11, 2022
Primary Completion Date
November 22, 2024
Completion Date
November 22, 2024
Last Updated
February 27, 2025
8
ACTUAL participants
Cepheid POC HCV Viremia (RNA) test
DIAGNOSTIC_TEST
HCV education from a health care provider
OTHER
Glecaprevir and Pibrentasvir
DRUG
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions